s6y
Company name or ticker
Search
Damora Therapeutics, Inc.
3
Cheng Andrew: Initial statement of beneficial ownership of securities
Filed
Thursday, August 13, 2026
Period
Aug 12, 2026
Accession number
0001193125-26-349515
Documents
3
3
EX-24
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header